Literature DB >> 22134591

MRSA: why have we got it and can we do anything about it?

B I Duerden1.   

Abstract

MRSA, first identified in 1960, became a major cause of healthcare-associated infection with the emergence of epidemic strains EMRSA 15 and 16 in the 1990 s. MRSA bacteraemia surveillance in England showed a peak of 7700 in 2003-2004. A target was set to halve MRSA bacteraemias by 2008 backed by a central improvement programme for infection prevention and control. Healthcare-associated infection is a patient safety issue with joint responsibility between: clinicians responsible for patient care; managers responsible for the organisation of services; and the government/Department of Health responsible for national strategy, prioritisation and performance management, together with introducing a statutory Code of Practice. By 2011, the number of MRSA bacteraemias had reduced by 80% to 1481. The key drivers of improvement were management responsibility, enhanced surveillance, adherence to clinical protocols and care bundles for invasive procedures, hand hygiene and environmental cleaning, and improved isolation procedures and antibiotic stewardship. The target has been translated into an ongoing MRSA objective, and further control of MRSA is supported by a screening programme aimed at all relevant hospital admissions. Sustaining the reduction will depend upon joint responsibility between management maintaining compliance assurance with policies and individual clinicians keeping it as a priority in patient safety.

Entities:  

Mesh:

Year:  2011        PMID: 22134591      PMCID: PMC3272211          DOI: 10.1038/eye.2011.314

Source DB:  PubMed          Journal:  Eye (Lond)        ISSN: 0950-222X            Impact factor:   3.775


  1 in total

Review 1.  Responsibility for managing healthcare-associated infections: where does the buck stop?

Authors:  B I Duerden
Journal:  J Hosp Infect       Date:  2009-09-17       Impact factor: 3.926

  1 in total
  2 in total

Review 1.  Chromogenic media for MRSA diagnostics.

Authors:  Zhenbo Xu; Yuchao Hou; Brian M Peters; Dingqiang Chen; Bing Li; Lin Li; Mark E Shirtliff
Journal:  Mol Biol Rep       Date:  2016-08-25       Impact factor: 2.316

2.  Methicillin-resistant Staphylococcus aureus (MRSA) in an Austrian urological department: 10 years experience covering 95.161 patients.

Authors:  Stefan Heidler; Friederike Asboth; Can Mert; Stephan Madersbacher
Journal:  World J Urol       Date:  2012-08-05       Impact factor: 4.226

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.